Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 112-123

  Kutzler, Michele A ^a   Robinson, Tara M ^a   Chattergoon, Michael A ^a   Choo, Daniel K ^b   Choo, Andrew Y ^c   Choe, Philip Y ^a   Ramanathan, Mathura P ^a   Parkinson, Rose ^a   Kudchodkar, Sagar ^a   Tamura, Yutaka ^d   Sidhu, Maninder ^e   Roopchand, Vidia ^e   Kim, J Joseph ^f   Pavlakis, George N ^g   Felber, Barbara K ^g   Waldmann, Thomas A ^g   Boyer, Jean D ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e PFIZER INC   (United States)

^f VGX Pharmaceuticals Inc   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 15; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 21244447927     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.112     Document Type: Article

References (71)

1. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
2. Marzo, A. L., V. Vezys, K. D. Klonowski, S. J. Lee, G. Muralimohan, M. Moore, D. F. Tough, and L. Lefrancois. 2004. Fully functional memory CD8 T cells in the absence of CD4 T cells. J. Immunol. 173: 969-975.
3. + T-cell responses. Curr. Opin. Immunol. 16: 259-263.
4. + T cell help. J. Infect. Dis. 189: 971-983.
5. Khanolkar, A., M. J. Fuller, and A. J. Zajac. 2004. CD4 T cell-dependent CD8 T cell maturation. J. Immunol. 172: 2834-2844.
6. Johansen, P., P. Stamou, R. E. Tascon, D. B. Lowrie, and B. Stockinger. 2004. CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells. Eur. J. Immunol. 34: 91-97.
7. + T cell responses in vivo. J. Immunol. 171: 6339-6343.
8. Bourgeois, C., and C. Tanchot. 2003. Mini-review CD4 T cells are required for CD8 T cell memory generation. Eur. J. Immunol. 33: 3225-3231.
9. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
10. + T lymphocytes. Nature 421: 852-856.
11. Shedlock, D. J., J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen. 2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170: 2053-2063.
12. + T cell to a fully functional tumor killer cell. Cancer Res. 62: 6438-6441.
13. Bourgeois, C., H. Veiga-Feraandes, A. M. Joret, B. Rocha, and C. Tanchot. 2002. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32: 2199-2207.
14. Wodarz, D. 2001. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance. J. Theor. Biol. 213: 447-459.
15. + T cells after acute infection. Nat. Immunol. 5: 927-933.
16. Cao, H., P. Kanki, J. L. Sankale, A. Dieng-Sarr, G. P. Mazzara, S. A. Kalams, B. Korber, S. Mboup, and B. D. Walker. 1997. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol. 71: 8615-8623.
17. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol 68: 4650-4655.
18. Rinaldo, C., X. L. Huang, Z. F. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, et al. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69: 5838-5842.
19. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
20. Unutmaz, D., P. Pileri, and S. Abrignani. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180: 1159-1164.
21. Tough, D. F., S. Sun, X. Zhang, and J. Sprent. 2000. Stimulation of memory T cells by cytokines. Vaccine 18: 1642-1648.
22. + memory T cells by opposing cytokines. Science 288: 675-678.
23. McKee, H. I., Y. T'Sao, P., M. Vera, P. Fortes, and D. S. Strayer. 2004. Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15. Genet. Vaccines Ther. 2: 10.
24. + T cell responses by DNA vaccination. J. Mol. Med. 81: 91-101.
25. Kirman, I., B. Vainer, and O. H. Nielsen. 1998. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm. Res. 47: 285-289.
26. + T cells. Int. J. Mol. Med. 14: 571-576.
27. Villinger, F., R. Miller, K. Mori, A. E. Mayne, P. Bostik, I. B. Sundstrom, C. Sugimoto, and A. A. Ansari. 2004. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 22: 3510-3521.
28. Lasek, W., G. Basak, T. Switaj, A. B. Jakubowska, P. J. Wysocki, A. Mackiewicz, N. Drela, A. Jalili, R. Kaminski, K. Kozar, et al. 2004. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice. Cancer Immunol. Immunother. 53: 363-372.
29. Umemura, M., H. Nishimura, K. Saito, T. Yajima, G. Matsuzaki, S. Mizuno, I. Sugawara, and Y. Yoshikai. 2003. Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guerin vaccination. Infect. Immun. 71: 6045-6048.
30. Calarota, S. A., M. Otero, K. Hermanstayne, M. Lewis, M. Rosati, B. K. Felber, G. N. Pavlakis, J. D. Boyer, and D. B. Weiner. 2003. Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques. J. Immunol. Methods 279: 55-67.
31. Oh, S., I. A. Berzofsky, D. S. Burke, T. A. Waldmann, and L. P. Perera. 2003. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc. Natl. Acad. Sci. USA 100: 3392-3397.
32. + T cell response following vaccination with peptide-pulsed dendritic cells. J. Immunol. 169: 4928-4935.
33. Min, W., H. S. Lillehoj, I. Burnside, K. C. Weining, P. Staeheli, and J. J. Zhu. 2001. Adjuvant effects of IL-1β, IL-2, IL-8, IL-15, IFN-α, IFN-γ TGF-β4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 20: 267-274.
34. Scheerlinck, J. P., G. Casey, P. McWaters, J. Kelly, D. Woollard, M. W. Lightowlers, J. M. Tennent, and P. J. Chaplin. 2001. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19: 4053-4060.
35. Meazza, R., P. L. Lollini, P. Nanni, C. De Giovanni, A. Gaggero, A. Comes, M. Cilli, E. Di Carlo, S. Ferrini, and P. Musiani. 2000. Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response. Int. J. Cancer 87: 574-581.
36. Xin, K. Q., K. Hamajima, S. Sasaki, T. Tsuji, S. Watabe, E. Okada, and K. Okuda. 1999. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine 17: 858-866.
37. Chang, S. Y., K. C. Lee, S. Y. Ko, H. J. Ko, and C. Y. Kang. 2004. Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants. Int. J. Cancer 111: 86-95.
38. + T cells in vivo by IL-15. Immunity 8: 591-599.
39. + T cells. J. Exp. Med. 196: 935-946.
40. + memory T cells generated in vitro from Listeria-immunized mice. Immunology 109: 450-460.
41. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrancois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831.
42. Tagaya, Y., R. N. Bamford, A. P. DeFilippis, and T. A. Waldmann. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4: 329-336.
43. Waldmann, T. A., and Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17: 19-49.
44. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264: 965-968.
45. Onu, A., T. Pohl, H. Krause, and S. Bulfone-Paus. 1997. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158: 255-262.
46. Bamford, R. N., A. P. DeFilippis, N. Azimi, G. Kurys, and T. A. Waldmann. 1998. The 5′ untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 160: 4418-4426.
47. Kim, J. J., L. K. Nottingham, J. I. Sin, A. Tsai, L. Morrison, J. Oh, K. Dang, Y. Hu, K. Kazahaya, M. Bennett, et al. 1998. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102: 1112-1124.
48. Ramanathan, M. P., E. Curley III, M. Su, J. A. Chambers, and D. B. Weiner. 2002. Carboxyl terminus of hVIP/mov34 is critical for HIV-1-Vpr interaction and glucocorticoid-mediated signaling. J. Biol. Chem. 277: 47854-47860.
49. Boyer, J. D., M. Chattergoon, K. Muthumani, S. Kudchodkar, J. Kim, M. Bagarazzi, G. Pavlakis, R. Sekaly, and D. B. Weiner. 2002. Next generation DNA vaccines for HIV-1. J. Liposome Res. 12: 137-142.
50. Robinson, H. L., C. A. Boyle, D. M. Feltquate, M. J. Morin, J. C. Santoro, and R. G. Webster. 1997. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs. J. Infect. Dis. 176(Suppl. 1): S50-S55.
51. Chattergoon, M. A., V. Saulino, J. P. Shames, J. Stein, L. J. Montaner, and D. B. Weiner. 2004. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 22: 1744-1750.
52. Tagaya, Y., G. Kurys, T. A. Thies, J. M. Losi, N. Azimi, J. A. Hanover, R. N. Bamford, and T. A. Waldmann. 1997. Generation of secretable and non-secretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA 94: 14444-14449.
53. Meazza, R., S. Verdiani, R. Biassoni, M. Coppolecchia, A. Gaggero, A. M. Orengo, M. P. Colombo, B. Azzarone, and S. Ferrini. 1996. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12: 2187-2192.
54. Yang, J. S., J. J. Kim, D. Hwang, A. Y. Choo, K. Dang, H. Maguire, S. Kudchodkar, M. P. Ramanathan, and D. B. Weiner. 2001. Induction of potent Th1-type immune responses from a novel DNA vaccine for west Nile virus New York isolate (WNV-NY 1999). J. Infect. Dis. 184: 809-816.
55. Mata, M., P. J. Travers, Q. Liu, F. R. Frankel, and Y. Paterson. 1998. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. J. Immunol. 161: 2985-2993.
56. + T-helper and a T-killer cell. Nature 393: 474-478.
57. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovinis in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044.
58. + T cells. Curr. Opin. Immunol. 10: 444-449.
59. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 1: 1138-1143.
60. Nishimura, H., K. Hiromatsu, N. Kobayashi, K. H. Grabstein, R. Paxton, K. Sugamura, J. A. Bluestone, and Y. Yoshikai. 1996. IL-15 is a novel growth factor for murine γ δ T cells induced by Salmonella infection. J. Immunol. 156: 663-669.
61. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 3810-3815.
62. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
63. McInnes, I. B., J. A. Gracie, M. Haraett, W. Harnett, and F. Y. Liew. 2003. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann. Rheum. Dis. 62(Suppl. 2): ii51-ii54.
64. Scola, M. P., S. D. Thompson, H. I. Brunner, M. K. Tsoras, D. Witte, M. A. Van Dijk, A. A. Grom, M. H. Passo, and D. N. Glass. 2002. Interferon-γ:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J. Rheumatol. 29: 369-378.
65. Waldmann, T. 2002. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res. 4(Suppl. 3): S161-S167.
66. Kaiser, P., L. Rothwell, D. Vasicek, and K. Hala. 2002. A role for IL-15 in driving the onset of spontaneous autoimmune thyroiditis? J. Immunol. 168: 4216-4220.
67. Lukic, M. L., E. Mensah-Brown, X. Wei, A. Shahin, and F. Y. Liew. 2003. Lack of the mediators of innate immunity attenuate the development of autoimmune diabetes in mice. J. Autoimmun. 21: 239-246.
68. Harada, S., M. Yamamura, H. Okamoto, Y. Morita, M. Kawashima, T. Aita, and H. Makino. 1999. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 42: 1508-1516.
69. Rothe, H., A. Hausmann, and H. Kolb. 2002. Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15. Horm. Metab. Res. 34: 7-12.
70. Losy, J., A. Niezgoda, and J. Zaremba. 2002. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 40: 151-153.
71. Ruchatz, H., B. P. Leung, X. Q. Wei, I. B. McInnes, and F. Y. Liew. 1998. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160: 5654-5660.